Background: Hearing loss is quite prevalent and affects people’s quality of life. To our knowledge, there are limited studies assessing the efficacy of hearing interventions onquality of life in adults. Therefore, we aim to conduct a randomized controlled trial (RCT) to determine the impact and cost-effectiveness of community-based hearing rehabilitation on quality of life among Chinese adults with hearing loss.Methods/design:In this two-arm feasibility study, participants aged 16 and above with some degree of hearing loss (n=464) will be recruited from Linyi City, Shandong Province. Theyare randomly assigned to the treatment group or the control group. Those in the treatment group are prescribed with hearing aids, while those in the control group receive no intervention. Reinstruction in use of devices is providedfor the treatment group during booster visits held 6 months post-randomization or unscheduled interim visits when necessary. Data arecollected at baseline and the follow-up 12 months later. The primary outcome ischanges in quality of life over a 12-month study period. Secondary outcomes include sub-dimensions in quality of life, physical functioning, chronic diseases, cognitive function, depression, social support, hospitalizations, falls and healthcarecosts. Finally, we will evaluate whether hearing aids intervention is cost-effectiveness to apply in a large scale.Discussion:The trialis designed to evaluate the impact and cost-effectiveness of a community-based rehabilitative intervention on quality of life among Chinese adults with hearing loss. We hope that it would help improve the well-being for Chinese adults and provide references inpolicy and practicefor China andother countries.Trial registration:Chinese Clinical Trial Registry,ChiCTR1900024739.Registered on 26 July 2019, http://www.chictr.org.cn/index.aspx.